Patents by Inventor Christina Ziegler

Christina Ziegler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • gM-negative EHV-mutants without heterologous elements
    Patent number: 8986707
    Abstract: The present invention relates to the field of animal health and in particular of Equine Herpes Viruses (EHV) wherein the gene encoding the protein gM is absent, and which is free of heterologous elements. Further aspects of the invention relate to pharmaceutical compositions comprising said viruses, uses thereof, and methods for the prophylaxis and treatment of EHV infections. The invention also relates to pharmaceutical compositions comprising the combination of EHV-1 and EHV-4 viruses wherein the gene encoding the protein gM is absent and which is free of heterologous elements.
    Type: Grant
    Filed: April 13, 2012
    Date of Patent: March 24, 2015
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Antonie Neubauer, Christina Ziegler
  • GM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS
    Publication number: 20120195927
    Abstract: The present invention relates to the field of animal health and in particular of Equine Herpes Viruses (EHV) wherein the gene encoding the protein gM is absent, and which is free of heterologous elements. Further aspects of the invention relate to pharmaceutical compositions comprising said viruses, uses thereof, and methods for the prophylaxis and treatment of EHV infections. The invention also relates to pharmaceutical compositions comprising the combination of EHV-1 and EHV-4 viruses wherein the gene encoding the protein gM is absent and which is free of heterologous elements.
    Type: Application
    Filed: April 13, 2012
    Publication date: August 2, 2012
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Antonie NEUBAUER, Christina ZIEGLER
  • gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS
    Publication number: 20090162396
    Abstract: The present invention relates to the field of animal health and in particular of Equine Herpes Viruses (EHV) wherein the gene encoding the protein gM is absent, and which is free of heterologous elements. Further aspects of the invention relate to pharmaceutical compositions comprising said viruses, uses thereof, and methods for the prophylaxis and treatment of EHV infections. The invention also relates to pharmaceutical compositions comprising the combination of EHV-1 and EHV-4 viruses wherein the gene encoding the protein gM is absent and which is free of heterologous elements.
    Type: Application
    Filed: February 25, 2009
    Publication date: June 25, 2009
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, GMBH
    Inventors: Antonie Neubauer, Christina Ziegler
  • gM-negative EHV-mutants without heterologous elements
    Patent number: 7524506
    Abstract: The present invention relates to the field of animal health and in particular of Equine Herpes Viruses (EHV) wherein the gene encoding the protein gM is absent, and which is free of heterologous elements. Further aspects of the invention relate to pharmaceutical compositions comprising said viruses, uses thereof, and methods for the prophylaxis and treatment of EHV infections. The invention also relates to pharmaceutical compositions comprising the combination of EHV-1 and EHV-4 viruses wherein the gene encoding the protein gM is absent and which is free of heterologous elements.
    Type: Grant
    Filed: October 19, 2006
    Date of Patent: April 28, 2009
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Antonie Neubauer, Christina Ziegler
  • gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS
    Publication number: 20070166330
    Abstract: The present invention relates to the field of animal health and in particular of Equine Herpes Viruses (EHV) wherein the gene encoding the protein gM is absent, and which is free of heterologous elements. Further aspects of the invention relate to pharmaceutical compositions comprising said viruses, uses thereof, and methods for the prophylaxis and treatment of EHV infections. The invention also relates to pharmaceutical compositions comprising the combination of EHV-1 and EHV-4 viruses wherein the gene encoding the protein gM is absent and which is free of heterologous elements.
    Type: Application
    Filed: October 19, 2006
    Publication date: July 19, 2007
    Inventors: Antonie Neubauer, Christina Ziegler
  • gM-negative EHV-mutants without heterologous elements
    Patent number: 7141243
    Abstract: The present invention relates to the field of animal health and in particular of Equine Herpes Viruses (EHV) wherein the gene encoding the protein gM is absent, and which is free of heterologous elements. Further aspects of the invention relate to pharmaceutical compositions comprising said viruses, uses thereof, and methods for the prophylaxis and treatment of EHV infections. The invention also relates to pharmaceutical compositions comprising the combination of EHV-1 and EHV-4 viruses wherein the gene encoding the protein gM is absent and which is free of heterologous elements.
    Type: Grant
    Filed: July 21, 2003
    Date of Patent: November 28, 2006
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Antonie Neubauer, Christina Ziegler
  • gM-negative EHV-mutants without heterologous elements
    Publication number: 20040109873
    Abstract: The present invention relates to the field of animal health and in particular of Equine Herpes Viruses (EHV) wherein the gene encoding the protein gM is absent, and which is free of heterologous elements. Further aspects of the invention relate to pharmaceutical compositions comprising said viruses, uses thereof, and methods for the prophylaxis and treatment of EHV infections. The invention also relates to pharmaceutical compositions comprising the combination of EHV-1 and EHV-4 viruses wherein the gene encoding the protein gM is absent and which is free of heterologous elements.
    Type: Application
    Filed: July 21, 2003
    Publication date: June 10, 2004
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Antonie Neubauer, Christina Ziegler